Medical Market Report

Global Emergency Contraceptives Market By Type (Combined estrogen and progestin pills, Progestin-only (as Levonorgestrel) pills, Antiprogestin (as mifepristone) pills, and Ulipristal acetate pills), By Application (Hospital pharmacies, Retail pharmacies, Online pharmacies, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 136399
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Emergency Contraceptives Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global emergency contraceptives market is segmented on the Type, Application, and geography.

    The worldwide market for Emergency Contraceptives Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Emergency Contraceptives Market Scope:

    By type, the market is segmented into Combined estrogen and progestin pills

    , Progestin-only (as Levonorgestrel) pills

    , Antiprogestin (as mifepristone) pills

    , and Ulipristal acetate pills. By Application, the market is divided into Hospital pharmacies

    , Retail pharmacies

    , Online pharmacies

    , and Others.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Genetics

    , Teva Pharmaceutical

    , Uniprix

    , Gavis Pharmaceuticals

    , HRA Pharma

    , and Mankind Pharma.

    Key Market Segments

    Type

    Combined estrogen and progestin pills

    Progestin-only (as Levonorgestrel) pills

    Antiprogestin (as mifepristone) pills

    Ulipristal acetate pills

    Application

    Hospital pharmacies

    Retail pharmacies

    Online pharmacies

    Others

    Key Market Players included in the report:

    Genetics

    Teva Pharmaceutical

    Uniprix

    Gavis Pharmaceuticals

    HRA Pharma

    Mankind Pharma

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Emergency Contraceptives Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Emergency Contraceptives Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Emergency Contraceptives Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Emergency Contraceptives Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Emergency Contraceptives Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Emergency Contraceptives Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Emergency Contraceptives sub-markets, depending on key regions (various vital states).
    To analyze Emergency Contraceptives Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Emergency Contraceptives Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide Emergency Contraceptives Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Emergency Contraceptives Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Emergency Contraceptives Market Overview
    

    3.1. Emergency Contraceptives Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Emergency Contraceptives Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Emergency Contraceptives Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Combined estrogen and progestin pills
    

      4.4. Progestin-only (as Levonorgestrel) pills
    

      4.5. Antiprogestin (as mifepristone) pills
    

      4.6. Ulipristal acetate pills5. Global Emergency Contraceptives Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Emergency Contraceptives Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospital pharmacies
    

      5.4. Retail pharmacies
    

      5.5. Online pharmacies
    

      5.6. Others6. Global Emergency Contraceptives Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Emergency Contraceptives Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Emergency Contraceptives Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Emergency Contraceptives Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Emergency Contraceptives Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Emergency Contraceptives Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Emergency Contraceptives Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Genetics
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Teva Pharmaceutical
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Uniprix
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Gavis Pharmaceuticals
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. HRA Pharma
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Mankind Pharma
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.